Sidqi Aulia, Departamento de Cardiología y Medicina Vascular, Facultad de Medicina, University of Jendral Achmad Yani/Dustira Army Hospital, Cimahi, Indonesia
Kevin Karim, Departamento de Cardiología y Medicina Vascular, Facultad de Medicina, University of Jendral Achmad Yani/Dustira Army Hospital, Cimahi, Indonesia
Irfan S. Pradisa, Departamento de Cardiología y Medicina Vascular, Facultad de Medicina, University of Jendral Achmad Yani/Dustira Army Hospital, Cimahi, Indonesia
Cyntia Septriyanti, Departamento de Cardiología y Medicina Vascular, Facultad de Medicina, University of Jendral Achmad Yani/Dustira Army Hospital, Cimahi, Indonesia
Moch F. Huda, Departamento de Cardiología y Medicina Vascular, Facultad de Medicina, University of Jendral Achmad Yani/Dustira Army Hospital, Cimahi, Indonesia
Arinta Setyasari, Departamento de Cardiología y Medicina Vascular, Facultad de Medicina, University of Jendral Achmad Yani/Dustira Army Hospital, Cimahi, Indonesia
Sherly Yosephina, Departamento de Cardiología y Medicina Vascular, Facultad de Medicina, University of Jendral Achmad Yani/Dustira Army Hospital, Cimahi, Indonesia
Nizamuddin Ubaidillah, Departamento de Cardiología y Medicina Vascular, Facultad de Medicina, University of Jendral Achmad Yani/Dustira Army Hospital; Cardiac Catheterization Laboratory, Dustira Army Hospital. Cimahi, Indonesia
Objective: To examine the relationship between PLR with GRACE and TIMI score in ACS patients. Materials and method: This study included 1,000 ACS patients who were assigned to the Cardiology Department at Dustira Army Hospital. Patient examination and medical record were completed from January 2019 to June 2020. Results: The GRACE risk score was substantially greater in the high PLR group compared to the moderate and low PLR groups [158 (144-174), 130 (114.5-149) and 124 (104- 147.75)], respectively (p < 0.000). Similarly, the high PLR group had significantly higher TIMI scores for unstable angina pectoris (UAP), non-ST-elevation myocardial infarction (NSTEMI), and ST-elevation myocardial infarction (STEMI) than the moderate and low PLR groups [3 (3-4), 3 (3-4), 3 (3-3), p = 0.001; 5 (4-5), 4 (4-5), 4.5 (4-5), p < 0.000, and 6 (5-7), 6 (5-6), 6 (5.5-6), p = 0.003]. In addition, GRACE risk score (r = 0.314, p < 0.000), TIMI risk score for UAP (r = 0.365, p < 0.000), TIMI risk score for NSTEMI (r = 0.314, p = 0.001), and TIMI risk score for STEMI (r = 0.227, p = 0.001) also had a favorable link with PLR. Conclusion: PLR is an inexpensive, convenient and reproducible laboratory marker in routine clinical practice that could predict the prognosis in patients with ACS.
Keywords: Platelet. Lymphocyte. Acute coronary syndrome. GRACE score. TIMI score.
